Table 2 Characteristics of included child and adolescent studies.
Country | Trauma sample | Pharmacotherapy | Timing after trauma | Comparator | n | PTSD/ASD outcome | Follow up | |
|---|---|---|---|---|---|---|---|---|
Nugent* | USA | Injury | Propranolol | <12 h | Placebo | 20 | PTSD Incidence & Severity (CAPS-CA) | 6 weeks |
Rosenberg et al.* | USA | Burns | Propranolol | <2 days | Standard therapy | 197 | PTSD Incidence (MAGIC) | 7 years |
Robert et al.* | USA | Burns | Imipramine | 36 days | Chloral hydrate | 25 | ASD Severity (Clinical Interview) | 36 days |
